tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Neurocrine (NBIX)
NASDAQ:NBIX
US Market
NBIX
Neurocrine
Overview
Analyst Forecasts
AI Stock Analysis
News & Insights
Financials
Dividends
Technical Analysis
Options
Chart
Earnings
Ownership
Historical Prices
Stock Buybacks
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Neurocrine (NBIX) Stock News & Sentiment

Compare
1,358 Followers
Positive Growth Outlook for Neurocrine Biosciences Driven by Ingrezza and Crenessity Sales Projections
Premium
Ratings
Positive Growth Outlook for Neurocrine Biosciences Driven by Ingrezza and Crenessity Sales Projections
21d ago
NBIX
Positive Market Outlook for Neurocrine’s Crenessity Driven by Unmet Needs and Strong Physician Adoption
Premium
Ratings
Positive Market Outlook for Neurocrine’s Crenessity Driven by Unmet Needs and Strong Physician Adoption
24d ago
NBIX
Promising Market Potential and Therapeutic Advancements Drive Buy Rating for Neurocrine’s Crenessity
Premium
Ratings
Promising Market Potential and Therapeutic Advancements Drive Buy Rating for Neurocrine’s Crenessity
1M ago
NBIX
Buy Rating on Neurocrine Due to Stabilization Prospects and Competitive Landscape Opportunities
Premium
Ratings
Buy Rating on Neurocrine Due to Stabilization Prospects and Competitive Landscape Opportunities
1M ago
NBIX
Neurocrine Biosciences Faces Market Adoption Challenges with CRENESSITY Launch
Premium
Company Announcements
Neurocrine Biosciences Faces Market Adoption Challenges with CRENESSITY Launch
1M ago
NBIX
Neurocrine’s Potential Upside: Buy Rating Amid Market Overreaction and Pipeline Prospects
Premium
Ratings
Neurocrine’s Potential Upside: Buy Rating Amid Market Overreaction and Pipeline Prospects
2M ago
NBIX
Neurocrine Biosciences’ Earnings Call: Record Sales & Strategic Growth
Premium
Company Announcements
Neurocrine Biosciences’ Earnings Call: Record Sales & Strategic Growth
2M ago
NBIX
More NBIX News >

NBIX News on the Web

Is Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD) a Strong ETF Right Now?
Zacks
Neutral
BB Biotech AG Reduces Stake in Black Diamond Therapeutics Inc
GuruFocus News
Neutral
Should Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD) Be on Your Investing Radar?
Zacks
Neutral
Neurocrine Biosciences Begins Phase 1 Study Of New VMAT2 Inhibitor For Neurological Conditions
Yahoo Finance
Neutral
Neurocrine Biosciences initiates trial of VMAT2 inhibitor in healthy adults
Clinical Trials Arena
Bullish
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?
Zacks
Neutral
Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX) and Medios AG (OtherMEDOF)
TipRanks News
Neutral
Xenon Q4 Loss Narrower Than Expected, Pipeline Development in Focus
Zacks
Neutral

News Score - Last 7 Days

Neutral
NBIX
Sector Average
Media Buzz
This Week2 articles
Weekly Average1.75 articles
News Sentiment
This Week50%
Sector Average61%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NBIX’s Media Buzz Sentiment?
2 articles about NBIX were published this week. In an average week, 1.75 articles are published.
    What is NBIX’s weekly average amount of articles?
    In an average week, 1.75 articles about NBIX are published.
      What is NBIX’s News Sentiment?
      50% of articles about NBIX were positive this week, compared to its sector average of 61%.
        Healthcare Stocks that are Trending in the News
        ALCAlcon
        SLNOSoleno Therapeutics
        DYAIDyadic International
        ASMBAssembly Biosciences
        CLGNCollplant Holdings
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing